Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?

Cerri S., du Bois R.M., Spagnolo P.

Source: Eur Respir J 2011; 37: 489-491

Journal Issue: March

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Cerri S., du Bois R.M., Spagnolo P.. Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?. Eur Respir J 2011; 37: 489-491

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Managing end stage disease in ILDs Source: ERS Course 2016 Year: 2016
Managing end stage disease in ILDs Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2018
Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease? Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013
Early and late onset asthma: are they the same? Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019
Tuberculosis: considerations on the period between disease beginning and diagnosis moment Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001
Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era? Source: Eur Respir J 2014; 43: 1233-1236 Year: 2014
Do airway diseases start in the early life? Source: ERS Course 2019 - Masterclass in airways disease 2019 Year: 2019
Presentation by an expert: IL33 and onset of chronic lung disease Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013
Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end Source: Eur Respir J, 52 (6) 1802111; 10.1183/13993003.02111-2018 Year: 2018
Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients? Source: Annual Congress 2013 –Sarcoidosis Year: 2013
Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004
Monitoring disease progression in COPD patients: one step beyond! Source: Eur Respir J 2014; 43: 665-667 Year: 2014
Radiological diagnosis of interstitial lung disease: is it all about pattern recognition? Source: Eur Respir J, 52 (2) 1801321; 10.1183/13993003.01321-2018 Year: 2018
Pulmonary involvement in inflammatory bowel disease Source: Annual Congress 2010 - Pulmonary involvement in disorders of the gastrointestinal system Year: 2010
Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
Targeted treatment of idiopathic pulmonary fibrosis: one step at a time Source: Eur Respir J 2016; 47:1321-1323 Year: 2016
The light at the end of the tunnel: is COPD prevalence changing? Source: Eur Respir J 2010; 36: 718-719 Year: 2010